Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice

Antiviral Activity of the Long Chain Pentraxin PTX3 against Influenza Viruses

(2014) P. C. Reading et al.   JOURNAL OF IMMUNOLOGY

Functions of Type II Pneumocyte-Derived Vascular Endothelial Growth Factor in Alveolar Structure, Acute Inflammation, and Vascular Permeability

(2010) Marco Mura et al.   AMERICAN JOURNAL OF PATHOLOGY

Influenza epidemiology—past, present, and future

(2010) Philippe R. S. Lagacé-Wiens et al.   CRITICAL CARE MEDICINE

Epidemic viral pneumonia

(2010) Stephen E Lapinsky   CURRENT OPINION IN INFECTIOUS DISEASES

Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury

(2010) Bing Han et al.   INTENSIVE CARE MEDICINE

Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality

(2010) Tommaso Mauri et al.   INTENSIVE CARE MEDICINE

Genetic Determinants of Mouse Hepatitis Virus Strain 1 Pneumovirulence

(2010) J. L. Leibowitz et al.   JOURNAL OF VIROLOGY

Proteasome Inhibition In Vivo Promotes Survival in a Lethal Murine Model of Severe Acute Respiratory Syndrome

(2010) X.-Z. Ma et al.   JOURNAL OF VIROLOGY

Regulation of leukocyte recruitment by the long pentraxin PTX3

(2010) Livija Deban et al.   NATURE IMMUNOLOGY

Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates

(2010) Saskia L. Smits et al.   PLoS Pathogens

An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm

(2009) Barbara Bottazzi et al.   Annual Review of Immunology

Pentraxins: Multifunctional proteins at the interface of innate immunity and inflammation

(2009) Livija Deban et al.   BIOFACTORS

Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity*

(2009) Tommaso Mauri et al.   CRITICAL CARE MEDICINE

PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation

(2009) Xiaolin He et al.   INTENSIVE CARE MEDICINE

Toll-Like Receptor 4 Deficiency Increases Disease and Mortality after Mouse Hepatitis Virus Type 1 Infection of Susceptible C3H Mice

(2009) A. Khanolkar et al.   JOURNAL OF VIROLOGY

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

(2009) Craig W. Day et al.   VIROLOGY

Alveolar Macrophages Are a Major Determinant of Early Responses to Viral Lung Infection but Do Not Influence Subsequent Disease Development

(2008) P. K. Pribul et al.   JOURNAL OF VIROLOGY

Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice

(2008) Xiaolin He et al.   PLoS One